RecruitingNCT03588481
IRIS- DESyne X2 in the IRIS-DES Registry
Evaluation of Effectiveness and Safety of DESyne X2 in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Sponsor
Seung-Jung Park
Enrollment
1,000 participants
Start Date
Nov 28, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.
Eligibility
Min Age: 19 Years
Inclusion Criteria3
- Age 19 and more
- Intervention with DeSyne X2 drug-eluting coronary stent
- Agreed with written informed consent form
Exclusion Criteria3
- Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time
- Life expectancy of 1year and under
- Cardiac shock
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEDESyne X2
Novolimus-eluting stent
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03588481
Related Trials
Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions
NCT067368994 locations
Evaluating New Radiation Techniques for Cardiovascular Imaging
NCT016215941 location
Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL)
NCT062732934 locations
Treatment of Functionally Non-significant Vulnerable Plaques in Patients With Multivessel ST-elevation Myocardial Infarction The VULNERABLE Trial
NCT0559906149 locations
Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)
NCT065355681 location